INMED PHARMACEUTICALS INC. Sale of Stock, Price Per Share
INMED PHARMACEUTICALS INC. (INM) had Sale of Stock, Price Per Share of $1.00 per share as of 2023-09-19, per its 10-Q filed 2024-02-13.
Discontinued › Notes › Equity
us-gaap:SaleOfStockPricePerShare · last filed 2024-02-13
- 2023-09-19: Sale of Stock, Price Per Share $1.00.
| Period end | Sale of Stock, Price Per Share |
|---|---|
| 2023-09-19 | $1.00 10-Q · filed 2024-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |